A rare presentation of enfortumab vedotin–induced toxic epidermal necrolysis
Author:
Publisher
Elsevier BV
Subject
Dermatology
Reference7 articles.
1. Enfortumab vedotin to treat urothelial carcinoma;Hanna;Drugs Today (Barc),2020
2. Enfortumab vedotin antibody-drug conjugate targeting nectin-4 is a highly potent therapeutic agent in multiple preclinical cancer models;Challita-Eid;Cancer Res,2016
3. Pivotal trial of enfortumab vedotin in urothelial carcinoma after platinum and anti-programmed death 1/programmed death ligand 1 therapy;Rosenberg;J Clin Oncol,2019
4. Nectin-4: A new prognostic biomarker for efficient therapeutic targeting of primary and metastatic triple-negative breast cancer;M-Rabet;Ann Oncol,2017
5. Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN): immunologic reactions;Zimmerman;Oncol Crit Care,2020
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Nectin-4-directed antibody-drug conjugates (ADCs): Spotlight on preclinical and clinical evidence;Life Sciences;2024-09
2. Enfortumab vedotin toxic epidermal necrolysis–like blistering dermatosis: A case series and review of the literature;JAAD Case Reports;2024-01
3. Cutaneous adverse reactions resulting from targeted cancer therapies: histopathologic and clinical findings;Human Pathology;2023-10
4. Innovative retargeted oncolytic herpesvirus against nectin4-positive cancers;Frontiers in Molecular Biosciences;2023-05-11
5. A Report of Polymorphous Toxic Erythema of Chemotherapy During Treatment with Enfortumab Vedotin for Metastatic Urothelial Cell Carcinoma;Michigan Journal of Medicine;2023-03-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3